Synbiotics in Amino Acid Formula: A New Strategy for Cow’s Milk Protein Allergy

Cow’s milk protein allergy (CMPA) is a common condition in infancy, often linked with disruptions in the gut microbiota. This systematic review and meta-analysis explores the role of amino acid formula (AAF) containing synbiotics as a potential nutritional strategy for infants with CMPA. It brings together findings from multiple randomised controlled trials that examine the clinical impact, microbiota changes, and broader health outcomes associated with AAF containing both prebiotics and Bifidobacterium breve M16-V.

Why This Resource Is Valuable for You

This peer-reviewed publication offers important, clinically relevant insights that will support your work in managing CMPA. By reviewing this resource, you will:

• Understand how AAF with synbiotics compares to standard AAF in allergy symptom resolution

• Learn how this approach may contribute to:

  • Fewer infections in infants with CMPA

  • Lower use of antibiotics and other medications

  • Reduced hospital admission rates and healthcare costs

• Examine the role of gut microbiota modulation, including increased Bifidobacterium and decreased adult-type species

• Apply findings to improve immune and digestive health outcomes in infants requiring specialized formula

This evidence can help you make more informed decisions when choosing formula options for infants with complex allergy needs.

Download and Access Further Information

For more detailed findings and to enhance your clinical knowledge, download the resource or click on the "View Content" link. Here you will find valuable data on the impact of AAF-Syn on CMPA treatment, with even more information within the full resource.